Overactive Bladder (OAB) Management: An Overview and Scope of Nano Drug Carriers

Author(s): Vikash Kumar*, Sandeep Rathor

Journal Name: Nanoscience & Nanotechnology-Asia

Volume 11 , Issue 6 , 2021

Article ID: e080121190007
Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


All groups/patient's quality of life (QOL) is affected because of overactive bladder (OAB), which leads to symptoms like urgency/urinary frequency/incontinence and nocturia. Several patients do not undergo management because of the embarrassment/misconception i.e. it is related to aging only and even discontinue the treatment due to side effects (repeated incidences). The objective of this review is to explore all management methods (including active ingredients involved in the treatment) and envisage the future scope of the different nano methods with minimizing apparent side effects to achieve a significant effect.

Keywords: OAB, QOL, management, methods, side effects, overactive bladder.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2021
Published on: 07 January, 2021
Article ID: e080121190007
Pages: 9
DOI: 10.2174/2210681210666210108111413
Price: $25

Article Metrics

PDF: 481